MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its division for research and diagnostic antibodies, AbD Serotec, will launch a series of novel anti-drug antibodies (ADAs) to strengthen its position as a leading provider of diagnostic reagents. Starting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan®) and Trastuzumab […]
Lucigen Corporation announced today that it has recently been awarded its largest SBIR Phase II grant to date to fund research and development of a point of care diagnostic test for influenza. The National Institutes of Health has awarded Lucigen a total of $2.8M in a Small Business Innovation Research grant to be used to […]
NOVATO, CA – Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that Uniscience is the new distributor authorized to sell, market, and support Biosearch’s inventoried and custom products in the country of Brazil. A few product lines in which Uniscience will focus their […]
AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated
BRANFORD, Conn., — HistoRx, the leader in quantitative immunohistochemistry, announces the application of their proprietary AQUA technology to assessment of messenger RNA in tissue. AQUA technology enables robust quantification and standardization of protein in tissue specimens; this new work extends the platform’s capabilities beyond protein expression analysis to quantification of nucleic acids. AQUA technology was […]
FAIRFIELD, Conn.–GE announced today that Sue Siegel has been named a GE Corporate Vice President and will serve as CEO of healthymagination, GE’s $6 billion global commitment to provide better health for more people by lowering costs and increasing access. “Sue Siegel’s great passion for advancing healthcare is matched by her keen understanding of innovation, […]
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced it has achieved CE IVD Mark registration in Europe for the diagnostic use of its proprietary WAVE MCE System and SURVEYOR® Scan KRAS Kit. Analysis of the KRAS gene is critical for treatment decision-making in many cancer types. Gaining the CE IVD Mark enables diagnostic product […]
Agilent Technologies Inc. (NYSE: A) and EQT, the Sweden-based private equity group, today announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based cancer diagnostic company. The $2.2 billion acquisition (on a debt-free basis) is the largest in Agilent’s history. “In the rapidly growing diagnostics market, Dako’s products and capabilities are […]
SALT LAKE CITY, — Lineagen today announced the Company completed the testing portion of a 9,000-person research study designed to confirm novel copy number genetic variants and novel next-generation sequence variants associated with autism spectrum disorder (ASD). These variants were discovered by Hakon Hakonarson, M.D., Ph.D., and his team at The Children’s Hospital of Philadelphia […]
EQT V has signed an agreement to sell Dako to the American listed technology company Agilent Technologies, for a total enterprise value of DKK 12.8 billion. Headquartered in California and listed on the New York Stock Exchange, Agilent Technologies has a market capitalization of around USD 15 billion. EQT V acquired Dako from the descendants […]
MADISON, N.J., — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic testing, information and services, has extended its endocrine diagnostics menu with the introduction of four new tests panels for congenital adrenal hyperplasia (CAH), an endocrine disorder found in newborns, children and women. The panels are designed to overcome limitations in conventional testing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
